Deciphera Pharmaceuticals Inc. (NASDAQ: NASDAQ:DCPH ) has experienced a meteoric rise in its stock price following the announcement of its acquisition by Ono Pharmaceutical for $2.4 billion. This strategic move has not only boosted investor confidence but also solidified Ono's position in the oncology space. However, with Deciphera's stock ( NASDAQ:DCPH ) trading...
